Report Detail

Medical Devices & Consumables Global Transcatheter Heart Valve Therapies Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4661385
  • |
  • 31 December, 2025
  • |
  • Global
  • |
  • 97 Pages
  • |
  • GIR
  • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Transcatheter Heart Valve Therapies market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Transcatheter heart valve therapies refer to minimally invasive procedures used to treat heart valve diseases, such as aortic stenosis or mitral regurgitation, without the need for open-heart surgery. During these procedures, a collapsible artificial valve is inserted into the heart via a catheter, typically through a blood vessel in the groin or chest. Once in position, the valve is expanded, replacing the damaged or diseased native valve and restoring proper blood flow. These innovative therapies offer significant advantages over traditional surgical approaches, including reduced recovery times, fewer complications, and improved outcomes for patients deemed high-risk or inoperable for conventional surgery.

This report is a detailed and comprehensive analysis for global Transcatheter Heart Valve Therapies market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Transcatheter Heart Valve Therapies market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2020-2031
Global Transcatheter Heart Valve Therapies market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2020-2031
Global Transcatheter Heart Valve Therapies market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2020-2031
Global Transcatheter Heart Valve Therapies market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (K US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Transcatheter Heart Valve Therapies
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Transcatheter Heart Valve Therapies market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Edwards Lifesciences, Mitralign, Cardiac Dimensions, NeoChord, Hanyu Medical, Valgen Medtech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Transcatheter Heart Valve Therapies market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Restorative Interventional Devices
Replacement Interventional Devices
Market segment by Application
Hospital
Clinic
Major players covered
Abbott
Edwards Lifesciences
Mitralign
Cardiac Dimensions
NeoChord
Hanyu Medical
Valgen Medtech
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Transcatheter Heart Valve Therapies product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Transcatheter Heart Valve Therapies, with price, sales quantity, revenue, and global market share of Transcatheter Heart Valve Therapies from 2020 to 2025.
Chapter 3, the Transcatheter Heart Valve Therapies competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Transcatheter Heart Valve Therapies breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Transcatheter Heart Valve Therapies market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Transcatheter Heart Valve Therapies.
Chapter 14 and 15, to describe Transcatheter Heart Valve Therapies sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Transcatheter Heart Valve Therapies Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Restorative Interventional Devices
    • 1.3.3 Replacement Interventional Devices
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Transcatheter Heart Valve Therapies Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospital
    • 1.4.3 Clinic
  • 1.5 Global Transcatheter Heart Valve Therapies Market Size & Forecast
    • 1.5.1 Global Transcatheter Heart Valve Therapies Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Transcatheter Heart Valve Therapies Sales Quantity (2020-2031)
    • 1.5.3 Global Transcatheter Heart Valve Therapies Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Abbott
    • 2.1.1 Abbott Details
    • 2.1.2 Abbott Major Business
    • 2.1.3 Abbott Transcatheter Heart Valve Therapies Product and Services
    • 2.1.4 Abbott Transcatheter Heart Valve Therapies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Abbott Recent Developments/Updates
  • 2.2 Edwards Lifesciences
    • 2.2.1 Edwards Lifesciences Details
    • 2.2.2 Edwards Lifesciences Major Business
    • 2.2.3 Edwards Lifesciences Transcatheter Heart Valve Therapies Product and Services
    • 2.2.4 Edwards Lifesciences Transcatheter Heart Valve Therapies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Edwards Lifesciences Recent Developments/Updates
  • 2.3 Mitralign
    • 2.3.1 Mitralign Details
    • 2.3.2 Mitralign Major Business
    • 2.3.3 Mitralign Transcatheter Heart Valve Therapies Product and Services
    • 2.3.4 Mitralign Transcatheter Heart Valve Therapies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Mitralign Recent Developments/Updates
  • 2.4 Cardiac Dimensions
    • 2.4.1 Cardiac Dimensions Details
    • 2.4.2 Cardiac Dimensions Major Business
    • 2.4.3 Cardiac Dimensions Transcatheter Heart Valve Therapies Product and Services
    • 2.4.4 Cardiac Dimensions Transcatheter Heart Valve Therapies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Cardiac Dimensions Recent Developments/Updates
  • 2.5 NeoChord
    • 2.5.1 NeoChord Details
    • 2.5.2 NeoChord Major Business
    • 2.5.3 NeoChord Transcatheter Heart Valve Therapies Product and Services
    • 2.5.4 NeoChord Transcatheter Heart Valve Therapies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 NeoChord Recent Developments/Updates
  • 2.6 Hanyu Medical
    • 2.6.1 Hanyu Medical Details
    • 2.6.2 Hanyu Medical Major Business
    • 2.6.3 Hanyu Medical Transcatheter Heart Valve Therapies Product and Services
    • 2.6.4 Hanyu Medical Transcatheter Heart Valve Therapies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Hanyu Medical Recent Developments/Updates
  • 2.7 Valgen Medtech
    • 2.7.1 Valgen Medtech Details
    • 2.7.2 Valgen Medtech Major Business
    • 2.7.3 Valgen Medtech Transcatheter Heart Valve Therapies Product and Services
    • 2.7.4 Valgen Medtech Transcatheter Heart Valve Therapies Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Valgen Medtech Recent Developments/Updates

3 Competitive Environment: Transcatheter Heart Valve Therapies by Manufacturer

  • 3.1 Global Transcatheter Heart Valve Therapies Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Transcatheter Heart Valve Therapies Revenue by Manufacturer (2020-2025)
  • 3.3 Global Transcatheter Heart Valve Therapies Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Transcatheter Heart Valve Therapies by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Transcatheter Heart Valve Therapies Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Transcatheter Heart Valve Therapies Manufacturer Market Share in 2024
  • 3.5 Transcatheter Heart Valve Therapies Market: Overall Company Footprint Analysis
    • 3.5.1 Transcatheter Heart Valve Therapies Market: Region Footprint
    • 3.5.2 Transcatheter Heart Valve Therapies Market: Company Product Type Footprint
    • 3.5.3 Transcatheter Heart Valve Therapies Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Transcatheter Heart Valve Therapies Market Size by Region
    • 4.1.1 Global Transcatheter Heart Valve Therapies Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Transcatheter Heart Valve Therapies Consumption Value by Region (2020-2031)
    • 4.1.3 Global Transcatheter Heart Valve Therapies Average Price by Region (2020-2031)
  • 4.2 North America Transcatheter Heart Valve Therapies Consumption Value (2020-2031)
  • 4.3 Europe Transcatheter Heart Valve Therapies Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Transcatheter Heart Valve Therapies Consumption Value (2020-2031)
  • 4.5 South America Transcatheter Heart Valve Therapies Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Transcatheter Heart Valve Therapies Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Transcatheter Heart Valve Therapies Sales Quantity by Type (2020-2031)
  • 5.2 Global Transcatheter Heart Valve Therapies Consumption Value by Type (2020-2031)
  • 5.3 Global Transcatheter Heart Valve Therapies Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Transcatheter Heart Valve Therapies Sales Quantity by Application (2020-2031)
  • 6.2 Global Transcatheter Heart Valve Therapies Consumption Value by Application (2020-2031)
  • 6.3 Global Transcatheter Heart Valve Therapies Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Transcatheter Heart Valve Therapies Sales Quantity by Type (2020-2031)
  • 7.2 North America Transcatheter Heart Valve Therapies Sales Quantity by Application (2020-2031)
  • 7.3 North America Transcatheter Heart Valve Therapies Market Size by Country
    • 7.3.1 North America Transcatheter Heart Valve Therapies Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Transcatheter Heart Valve Therapies Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Transcatheter Heart Valve Therapies Sales Quantity by Type (2020-2031)
  • 8.2 Europe Transcatheter Heart Valve Therapies Sales Quantity by Application (2020-2031)
  • 8.3 Europe Transcatheter Heart Valve Therapies Market Size by Country
    • 8.3.1 Europe Transcatheter Heart Valve Therapies Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Transcatheter Heart Valve Therapies Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Transcatheter Heart Valve Therapies Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Transcatheter Heart Valve Therapies Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Transcatheter Heart Valve Therapies Market Size by Region
    • 9.3.1 Asia-Pacific Transcatheter Heart Valve Therapies Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Transcatheter Heart Valve Therapies Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Transcatheter Heart Valve Therapies Sales Quantity by Type (2020-2031)
  • 10.2 South America Transcatheter Heart Valve Therapies Sales Quantity by Application (2020-2031)
  • 10.3 South America Transcatheter Heart Valve Therapies Market Size by Country
    • 10.3.1 South America Transcatheter Heart Valve Therapies Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Transcatheter Heart Valve Therapies Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Transcatheter Heart Valve Therapies Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Transcatheter Heart Valve Therapies Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Transcatheter Heart Valve Therapies Market Size by Country
    • 11.3.1 Middle East & Africa Transcatheter Heart Valve Therapies Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Transcatheter Heart Valve Therapies Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Transcatheter Heart Valve Therapies Market Drivers
  • 12.2 Transcatheter Heart Valve Therapies Market Restraints
  • 12.3 Transcatheter Heart Valve Therapies Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Transcatheter Heart Valve Therapies and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Transcatheter Heart Valve Therapies
  • 13.3 Transcatheter Heart Valve Therapies Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Transcatheter Heart Valve Therapies Typical Distributors
  • 14.3 Transcatheter Heart Valve Therapies Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Transcatheter Heart Valve Therapies. Industry analysis & Market Report on Transcatheter Heart Valve Therapies is a syndicated market report, published as Global Transcatheter Heart Valve Therapies Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Transcatheter Heart Valve Therapies market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report